Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

China Pharma Holdings (CPHI) Operating Expenses (2016 - 2025)

China Pharma Holdings (CPHI) has disclosed Operating Expenses for 16 consecutive years, with $568491.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Operating Expenses rose 0.51% year-over-year to $568491.0, compared with a TTM value of $2.8 million through Sep 2025, up 4.43%, and an annual FY2024 reading of $2.6 million, up 5.36% over the prior year.
  • Operating Expenses was $568491.0 for Q3 2025 at China Pharma Holdings, up from $565110.0 in the prior quarter.
  • Across five years, Operating Expenses topped out at $1.2 million in Q4 2022 and bottomed at $309647.0 in Q2 2023.
  • Average Operating Expenses over 5 years is $689208.0, with a median of $575403.0 recorded in 2023.
  • The sharpest move saw Operating Expenses plummeted 53.38% in 2021, then soared 50.24% in 2025.
  • Year by year, Operating Expenses stood at $950626.0 in 2021, then increased by 27.46% to $1.2 million in 2022, then decreased by 8.78% to $1.1 million in 2023, then decreased by 6.32% to $1.0 million in 2024, then crashed by 45.1% to $568491.0 in 2025.
  • Business Quant data shows Operating Expenses for CPHI at $568491.0 in Q3 2025, $565110.0 in Q2 2025, and $622557.0 in Q1 2025.